Biogen And Eisai Present Positive Results For Experimental Alzheimer’s Drug

Drugmakers Eisai and Biogen presented positive results of their much-anticipated experimental Alzheimer’s drug BAN-2401 today at the Alzheimer’s Association International Conference in Chicago. But doctors still have questions.

Read the full post on Forbes - Healthcare